However, by exploiting secondary variability in ligand availability across experimental conditions—such as levels of CIN or cancer cell STING expression (Extended Data Fig. 4c)—we distinguished ligand effects from genes merely co-expressed with the relevant receptor (Fig. 3b,c and Extended Data Fig. 4c). This evidence concerns the gene STING1 and cancer.